Supplementary Data 1 from Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

André Oberthuer, Matthias Fischer, Andreas Faldum et al.|Unknown|2023

Cited by 0